P821: The use of postpartum long-acting reversible contraceptives among women with genetic conditions

Interpregnancy intervals shorter than 6 months are associated with increased maternal and fetal risks. Studies have shown that women with genetic conditions are at a higher risk for pregnancy complications. Additionally, national databases indicate that medically complex women are at an increased risk for unintended pregnancy. Long-acting reversible contraception (LARC) is a strong recommendation for women at higher risk for adverse health events resulting from a future pregnancy. Understanding the use of LARC amongst this population is imperative for preventing complications associated with unintended pregnancies, short interpregnancy intervals, and maternal genetic conditions.